#USA #Washington #Heart Failure #Mortality Rates #HF Stats

Introduction

The Heart Failure Society of America (HFSA) has recently published its HF Stats 2026 report, shedding light on the concerning reality of heart failure (HF) in the United States. This comprehensive analysis examines the rising trends in heart failure prevalence and mortality, with particular emphasis on a demographic that was previously thought to be less vulnerable: younger adults.

Key Findings

According to the report, heart failure was responsible for approximately 452,573 deaths in the U.S. in 2023, accounting for about 14.6% of all deaths. Notably, mortality rates linked to heart failure have surged by around 37% since 2010, undoing a decade's worth of progress in combating this devastating condition. Alarmingly, data for early 2024 suggests that this upward trend shows no signs of abating.

One of the most startling revelations from the HF Stats 2026 report is the rising incidence of heart failure among individuals under 65 years old. Between 2010 and 2022, hospitalization rates due to heart failure increased among this age group, contrasting sharply with a decline observed among older adults. Crude mortality rates for heart failure skyrocketed by 121% among those aged 25-44 and by 96% among individuals aged 45-64 from 2001 to 2020.

Dr. Eiran Gorodeski, the director of the Advanced Heart Failure Transplant Center in Cleveland, Ohio, and 2026 Chair of the HFSA HF Stats Committee, remarked, ‘We have made significant advances in treating heart failure, yet at the population level, the burden of heart failure continues to worsen. The data shows that not only are more Americans at risk, but mortality rates are rising, predominantly affecting younger adults. This highlights the critical need to translate existing knowledge into proactive prevention, early detection, and the broader application of effective therapies.’

Growing Challenge

Heart failure remains one of America’s leading cardiovascular health challenges. Reports indicate that nearly one in four Americans will develop heart failure over their lifetime. Furthermore, about one-third of U.S. adults who appear asymptomatic already meet criteria for Stage A heart failure, categorizing them as being at risk. Presently, around 7.7 million American adults live with heart failure, and projections estimate this figure will surge to 8.7 million by 2030, reaching 10.3 million by 2040, and escalating to 11.4 million by 2050. This looming increase is primarily driven by an aging population alongside rising rates of obesity, hypertension, and other cardiometabolic risk factors.

Comprehensive Findings

The HF Stats 2026 report outlines 12 pivotal findings that capture the current state of heart failure and the various systems involved in its prevention and treatment. Among these findings:

• - Disparities Persist: The report highlights continued racial, ethnic, and geographic disparities in heart failure outcomes. Specifically, Black individuals exhibit the highest age-adjusted incidence and mortality rates related to heart failure.
• - Underutilization of Proven Therapies: Effective therapies for heart failure, particularly guideline-directed medical therapy (GDMT), are woefully underused. Real-world data indicate that only about 18% of the over three million patients with heart failure with reduced ejection fraction receive quadruple GDMT.
• - Economic Impact: The financial repercussions of heart failure are staggering, with estimates for 2020 ranging from $46 billion in direct and indirect costs to a staggering $312 billion when including broader healthcare expenses. Projections indicate these costs will rise significantly by 2050.
• - Unrecognized Conditions: The report draws attention to certain specific cardiomyopathies that remain underdiagnosed. Notably, transthyretin amyloid cardiomyopathy (ATTR-CM), hypertrophic cardiomyopathy (HCM), and genetic cardiomyopathies are increasingly relevant, the latter being attributed to 16% to 36% of dilated cardiomyopathy cases.
• - Advanced Heart Failure Issues: There remains a marked unmet need regarding advanced heart failure and cardiogenic shock, which affects between 350,000 and 500,000 adults in the U.S. annually.
• - Workforce Needs: The report also identifies critical workforce challenges within heart failure care. As of June 2025, only 1,523 Advanced Heart Failure and Transplant Cardiology-certified physicians were available, highlighting gaps in staffing across various heart failure management programs.

Conclusion

The HF Stats 2026 report not only catalogs alarming data surrounding heart failure but also establishes a clarion call for action. To effectively address these pressing health challenges, there is an urgent need for greater awareness, improved prevention strategies, enhanced recognition of symptoms, expanded use of successful treatments, and ongoing research into heart failure management. For further details and to delve deeper into the report's findings, the HFSA invites you to explore the upgraded HFStats.org platform which provides a wealth of information on heart failure statistics, resources, and publications. Together, we can work towards reducing the burden of heart failure and improving outcomes for all Americans afflicted by this serious condition.